Prepartum maternal chromium propionate supplementation improves neonatal calf antioxidant status by reshaping meconium microbiota and butyrate metabolism

Authors:

Abstract
Neonatal calves experience considerable oxidative and metabolic challenges during the transition from intrauterine to extrauterine life, but whether maternal chromium propionate (CrPro) supplementation before calving improves neonatal antioxidant status through early-life microbial metabolism remains unclear. This study evaluated the effects of prepartum maternal CrPro supplementation on antioxidant capacity and microbial metabolic characteristics in neonatal calves. Forty-eight prepartum Holstein cows were randomly assigned to 3 dietary treatments (16 cows per treatment). After application of prespecified eligibility criteria, 30 dam–calf pairs were analyzed (10 replicates per treatment; maternal body weight, 651.87 ± 2.84 kg; parity, 2.40 ± 0.13; body condition score, 3.48 ± 0.03; means ± SEM). From 21 d before expected calving until parturition, cows received a basal total mixed ration without supplemental CrPro (Con) or the same ration supplemented with CrPro at 10 g·cow⁻¹·d⁻¹ (CrL) or 20 g·cow⁻¹·d⁻¹ (CrH), providing 4 and 8 mg Cr(III)·cow⁻¹·d⁻¹, respectively. Calf blood and meconium samples were collected within 30 min after birth and before colostrum intake. Calves in the CrH group had greater body weight than Con calves at birth and at 7 and 14 d of age (P ≤ 0.05). Maternal CrPro supplementation dose-dependently increased calf plasma Cr(III). Compared with Con, CrH increased total antioxidant capacity (P < 0.05) and catalase activity (P < 0.001), decreased malondialdehyde (P < 0.01), and increased meconium short-chain fatty acid concentrations (P < 0.001). Plasma Cr(III) was positively correlated with antioxidant and short-chain fatty acid measures and negatively correlated with malondialdehyde (all P < 0.05). Metagenomic analysis indicated that CrH enriched a butyrate-producing microbial consortium, strengthened microbial co-occurrence networks, and increased the microbial potential for butyrate synthesis. Plasma metabolomics identified the oxidized phosphatidylcholine PAz-PC as a major negative mediator of catalase activity. Integrated analyses suggested two complementary pathways: meconium butyrate may enhance catalase activity through Nrf2/HO-1 signaling, whereas reduced plasma PAz-PC may relieve catalase inhibition. In conclusion, prepartum maternal CrPro supplementation improved antioxidant capacity in newborn calves, potentially through enrichment of butyrate-producing bacteria and attenuation of PAz-PC-associated catalase inhibition, providing a maternal nutritional strategy to support early-life antioxidant health in neonatal ruminants.